IRIS Institutional Research Information System - OPENBS Open Archive UniBS

METRA, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 63.595
EU - Europa 37.384
AS - Asia 24.510
AF - Africa 137
SA - Sud America 108
OC - Oceania 85
Continente sconosciuto - Info sul continente non disponibili 77
AN - Antartide 1
Totale 125.897
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 63.387
UA - Ucraina 10.684
CN - Cina 10.462
IT - Italia 5.737
HK - Hong Kong 5.355
SG - Singapore 4.860
RU - Federazione Russa 4.835
DE - Germania 4.187
PL - Polonia 3.459
FI - Finlandia 2.409
TR - Turchia 2.085
IE - Irlanda 1.921
GB - Regno Unito 1.737
FR - Francia 1.176
IN - India 1.158
SE - Svezia 598
CA - Canada 171
VN - Vietnam 134
BE - Belgio 114
QA - Qatar 114
NL - Olanda 112
CZ - Repubblica Ceca 107
MU - Mauritius 84
AU - Australia 77
EU - Europa 76
ID - Indonesia 61
ES - Italia 47
JP - Giappone 46
BR - Brasile 45
EE - Estonia 45
IR - Iran 43
KR - Corea 42
RO - Romania 39
AT - Austria 26
CH - Svizzera 23
EG - Egitto 17
PH - Filippine 17
PK - Pakistan 17
AR - Argentina 14
CL - Cile 14
GR - Grecia 14
HU - Ungheria 14
SA - Arabia Saudita 14
CO - Colombia 13
MX - Messico 13
TH - Thailandia 13
AL - Albania 12
BG - Bulgaria 12
SK - Slovacchia (Repubblica Slovacca) 11
MK - Macedonia 10
TW - Taiwan 10
ZA - Sudafrica 10
AE - Emirati Arabi Uniti 9
PT - Portogallo 9
AZ - Azerbaigian 8
KZ - Kazakistan 8
NZ - Nuova Zelanda 8
PA - Panama 8
LU - Lussemburgo 7
LV - Lettonia 7
PE - Perù 7
TN - Tunisia 7
IL - Israele 6
IQ - Iraq 6
LA - Repubblica Popolare Democratica del Laos 6
MA - Marocco 6
MY - Malesia 6
SI - Slovenia 6
VE - Venezuela 6
EC - Ecuador 5
LK - Sri Lanka 5
NO - Norvegia 5
UZ - Uzbekistan 5
BZ - Belize 4
DK - Danimarca 4
KG - Kirghizistan 4
LT - Lituania 4
UG - Uganda 4
DZ - Algeria 3
HR - Croazia 3
JO - Giordania 3
OM - Oman 3
RS - Serbia 3
TM - Turkmenistan 3
BA - Bosnia-Erzegovina 2
BD - Bangladesh 2
BS - Bahamas 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
CU - Cuba 2
ET - Etiopia 2
FK - Isole Falkland (Malvinas) 2
HT - Haiti 2
IS - Islanda 2
KW - Kuwait 2
UY - Uruguay 2
A1 - Anonimo 1
BY - Bielorussia 1
CY - Cipro 1
GS - Georgia del Sud e Isole Sandwich Australi 1
Totale 125.887
Salva come PNG Salva come JPEG
Città #
Fairfield 8.125
Jacksonville 7.990
Woodbridge 6.023
Hong Kong 5.337
Ashburn 4.234
Houston 4.117
Chandler 4.081
Singapore 3.938
Moscow 3.809
Cambridge 3.588
Princeton 3.516
Warsaw 3.429
Wilmington 3.420
Ann Arbor 3.254
Seattle 3.040
Nanjing 2.751
Dublin 1.907
Istanbul 1.781
Beijing 1.539
New York 1.330
Helsinki 1.074
Nanchang 1.033
Des Moines 803
Hebei 661
Shenyang 660
Milan 540
Changsha 538
San Diego 497
Tianjin 471
Jiaxing 446
Brescia 410
Dearborn 375
Jinan 370
Kunming 312
Shanghai 292
Kocaeli 247
Verona 229
Hangzhou 228
Rome 228
Romola 221
London 203
Boardman 155
Lancaster 139
Ningbo 134
Los Angeles 131
Munich 131
Lanzhou 125
Pune 121
Zhengzhou 121
Dong Ket 120
Doha 114
Taizhou 105
Brussels 104
Norwalk 102
San Francisco 102
Haikou 99
Lappeenranta 91
Toronto 91
Orange 89
Brno 80
Frankfurt am Main 76
Guangzhou 76
Changchun 75
Florence 68
Fuzhou 65
Kilburn 61
Taiyuan 58
Washington 53
Saint Petersburg 49
Palermo 48
Redwood City 48
San Mateo 47
Napoli 46
Tallinn 45
Jakarta 40
Naples 39
Chicago 33
Augusta 32
Bari 32
Bologna 31
Chiswick 31
Catania 30
Melbourne 30
Falkenstein 28
Phoenix 27
São Paulo 27
Tokyo 26
Trieste 26
Ottawa 25
Acton 24
Padova 24
Seongnam 23
Turin 23
Strasbourg 22
Hefei 21
Leawood 21
Olomouc 21
Pavia 21
Prescot 21
Westminster 21
Totale 90.715
Salva come PNG Salva come JPEG
Nome #
Metabolic exercise test data combined with cardiac and kidney indexes, the MECKI score: A multiparametric approach to heart failure prognosis 3.090
Un caso di Sindrome di Bland-White-Garland: origine anomala dell’arteria coronaria sinistra dall’arteria polmonare. 664
Inodilatatori: perché e quali. 370
American College of Cardiology; American Heart Association Task Force; European Society of Cardiology Committee for Practice Guidelines. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). 340
Farmaci inotropi non digitalici. 332
Effect of nesiritide in patients with acute decompensated heart failure. 318
Il genotipo DD per il gene dell’enzima di conversione dell’angiotensina identifica i pazienti con insufficienza cardiaca che possono beneficiare di dosi medio elevate di ACE inibitori. 303
Livelli circolanti del marcatore tumorale CA 125 in pazienti con scompenso cardiaco cronico:relazione con la classe NYHA, i parametri ecocardiografici e variazioni indotte dalla terapia. 294
La cardiomioplastica dinamica come trattamento della cardiomiopatia dilatativa ingravescente. 277
Worsening renal function in patients hospitalised for acute heart failure: Clinical implications and prognostic significance 273
The predictive value of short-term changes in hemoglobin concentration in patients presenting with acute decompensated heart failure 248
Impact of serial troponin release on outcomes in patients with acute heart failure: Analysis from the protect pilot study 246
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 239
Hemodynamic Predictors of Heart Failure Morbidity and Mortality: Fluid or Flow? 231
I polimorfismi Arg16Gly del gene recettore beta-2 adrenergico influenzano i parametri emodinamici e la prognosi dei pazienti con insufficienza cardiaca 227
Can we improve the treatment of congestion in heart failure? 221
Worsening renal function in patients hospitalised for acute heart failure: clinical implications and prognostic significance. 216
Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure 214
Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function. 214
May 2020 at a glance: ischaemic heart failure and sex-related differences 214
Effects of the long-term administration of nebivolol on the clinical symptoms, exercise capacity, and left ventricular function of patients with diastolic dysfunction: results of the ELANDD study. 213
Role of beta1- and alpha2c-adrenergic receptor polymorphisms and their combination in heart failure: a case-control study 212
Acute heart failure: multiple clinical profiles and mechanisms require tailored therapy. 211
Old and new intravenous inotropic agents in the treatment of advanced heart failure 208
Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial 207
Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European society of cardiology and endorsed by the European society of intensive care medicine 207
I polimorfismi Arg16 Gly del gene recettore beta-2 adrenergico influenzano i parametri emodinamici e la prognosi dei pazienti con insufficienza cardiaca. 202
Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. 202
Early dyspnoea relief in acute heart failure: prevalence, association with mortality, and effect of rolofylline in the PROTECT Study 198
Highlights of the 2009 scientific sessions of the European Society of Cardiology. 194
Postdischarge assessment after a heart failure hospitalization: the next step forward. 192
Troponin I in acute decompensated heart failure: insights from the ASCEND-HF study 192
Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial. 191
Should beta-blocker therapy be reduced or withdrawn after an episode of decompensated heart failure? Results from COMET. 191
Troponin T levels in patients with acute heart failure : clinical and prognostic significance of their delection and release during hospitalisation 191
L’ indice di performance miocardica ( MPI ) è un importante indicatore prognostico nei pazienti affetti da insufficienza cardiaca cronica. 190
Early drop in systolic blood pressure and worsening renal function in acute heart failure: renal results of Pre-RELAX-AHF. 183
Nebivolol: haemodynamic effects and clinical significance of combined beta-blockade and nitric oxide release. 171
Use of inotropic agents in patients with advanced heart failure: lessons from recent trials and hopes for new agents. 166
Task Force sullo Scompenso Cardiaco Acuto della Societa Europea di Cardiologia. Versione italiana a cura di A Gavazzi, M Metra. Riassunto esecutivo delle linee guida sulla diagnosi e trattamento dello scompenso cardiaco acuto. 164
Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes. 163
Beta-blocker treatment of patients with diastolic heart failure and arterial hypertension. A prospective, randomized, comparison of the long-term effects of atenolol vs. nebivolol. 160
Determinazione dell’equilibrio simpato-vagale attraverso l’analisi spettrale della variabilità della frequenza cardiaca in pazienti con insufficienza cardiaca di diverso grado di severità. 155
Efficacia di un nuovo diuretico, la muzolimina, in pazienti con insufficienza cardiaca. 154
Characteristics and mid-term follow-up of a single-center population affected by Tako-Tsubo cardiomyopathy 153
Effectiveness of MitraClip therapy in patients with refractory heart failure 152
The role of n-3 PUFAs in preventing the arrhythmic risk in patients with idiopathic dilated cardiomyopathy. 150
Left ventricular reverse remodelling predicts long-term outcomes in patients with functional mitral regurgitation undergoing MitraClip therapy: results from a multicentre registry 150
Multiparametric prognostic scores in chronic heart failure with reduced ejection fraction: A long-term comparison 149
Advanced chronic heart failure: A position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Societyof Cardiology 148
Effects of the Adenosine A(1) Receptor Antagonist Rolofylline on Renal Function in Patients With Acute Heart Failure an Renal Dysfunction Results From PROTECT (Placebo-Controlled Randomized Study of the Selective A(1) Adenosine ReceptorAntagonist Rolofylline for Patients Hospitalized With Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function) 148
Effetti cardiovascolari della ventilazione servo-adattativa (ASV) in pazienti affetti da apnee notturne e scompenso cardiaco cronico con disfunzione sistolica ventricolare sinistra 147
Percutaneous edge-to-edge mitral valve repair for the treatment of acute mitral regurgitation complicating myocardial infarction: A single centre experience 147
Fattori di rischio ed “epidemiologia inversa” nei pazienti con insufficienza cardiaca. 146
Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials. 146
Sindromi coronariche acute: ruolo dell’infezione cronica da Helicobacter Pylori e Citomegalovirus. 145
Self-expanding transcatheter aortic valve implantation for degenerated small Mitroflow bioprosthesis: Early and midterm outcomes 145
Amino acids and derivatives, a new treatment of chronic heart failure? 144
Mitraclip therapy in patients with functional mitral regurgitation and missing leaflet coaptation: is it still an exclusion criterion? 139
January 2017 at a glance: oncology, diabetes and antidiabetic treatment, pulmonary hypertension 139
Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry 134
Effects of ivabradine on endothelial function, aortic properties and ventricular-arterial coupling in chronic systolic heart failure patients 132
A randomized double-blind crossover study of nicardipine and nifedipine in patients with angina pectoris and concomitant essential hypertension. 131
A drastic complex atheromatous aorta. A case report. 130
Systemic lupus erythematosus and endothelial dysfunction: A close relationship 128
Effects of serelaxin in patients with acute heart failure 127
An unusual case of myocardial infarction 125
Acute heart failure congestion and perfusion status – impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry 125
Years-needed-to-treat to add 1 year of life: a new metric to estimate treatment effects in randomized trials. 124
Adrenergic receptor gene polymorphism and left ventricular reverse remodelling after cardiac resynchronization therapy: preliminary results 124
Acute hemodynamic effects of the two dopaminergic agonists ibopamine and dihydroergotamine, a comparison with the parent compound. 123
Effect of High dose of atorvastatin versus moderate dose on endothelial function and inflammatory biomarkers in patients with STEMI 123
Endothelial Dysfunction And Vascular Stiffness In Women With A Previous Pregnancy Complicated By Early Or Late Preeclampsia. 123
Prognostic Value of Serial Clinical, Laboratory and Ecocardiographic Tests in Ambulatory Patients with Chronic Heart Failure 122
n-3 PUFAs and cardiovascular disease prevention. 121
The puzzle of kidney dysfunction in heart failure: an introduction. 120
The PROTECT in-hospital risk model: 7-day outcome in patients hospitalized with acute heart failure and renal dysfunction 120
Consistent survival benefit of carvedilol over metoprolol irrespective of baseline characteristics of heart failure patients – Mode of death evaluation in COMET. 119
Nutritional Supplementation with Amino Acids in Ambulatory Patients with Idiophatic Dilatated Cardiomyophaty 119
Acute and chronic effects of the dihydropyridine calcium antagonist nisoldipine on the resting and exercise hemodynamics, neurohumoral parameters, and functional capacity of patients with chronic heart failure. 118
Are Beta-1 and alpha2c-adrenergic receptor polymorphisms associated with an increased risk of heart failure in Caucasian subjects: results of a case-control study 118
Neurohormonal activation in acute heart failure: results from VERITAS 117
A case of iatrogenic severe mitral regurgitation 117
Insights into cardiac alterations after pre-eclampsia: an echocardiographic study. 117
A rationale for the use of BETA-blockers as standard treatment for heart failure 116
Beta- adrenergic receptors polymorphisms and response to CRT 116
Endothelial Dysfunction In Early Systemic Lupus Erythematosus Patients And Controls Without Previous Cardiovascular Events. 116
Elastic aortic properties in patients with X syndrome 115
Ritmo circadiano della frequenza cardiaca in fibrillanti trattati con digossina e gitoformato. 114
Effects of aldosterone blockers on left ventricular function and remodeling in patients with mild-moderate chronic heart failure. 114
Angiotensin-converting-enzyme gene polymorphism and heart failure: a case-control study. 114
The role of plasma biomarkers in acute heart failure. Serial changes and independent prognostic value of NT-proBNP and cardiac troponin-T 114
The management of acute heart failure. 114
Raised homocystein plasma concentration in patients with heart failure: Clinical significance 114
Effects of spironolactone on ventricular-arterial coupling in patients with chronic systolic heart failure and mild symptoms 114
Mechanism of cardiovascular toxicity by proteasome inhibitors: new paradigm derived from clinical and pre-clinical evidence 114
Clinical Presentation and Outcome in a Contemporary Cohort of Patients with Acute Myocarditis: The Multicenter Lombardy Registry 114
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial 114
Acute and chronic effects of nisoldipine in patients with chronic heart failure. 113
Can we prevent or treat renal dysfunction in acute heart failure? 113
Totale 20.182
Salva come PNG Salva come JPEG
Categoria #
all - tutte 736.243
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 736.243
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202014.439 0 0 0 0 0 0 2.347 3.233 1.866 3.631 1.227 2.135
2020/202121.566 480 2.632 518 2.690 725 2.661 1.092 2.659 3.206 2.019 2.169 715
2021/202211.535 453 2.282 230 767 247 621 378 983 646 1.315 1.114 2.499
2022/202312.162 1.998 252 133 995 1.079 3.565 47 1.195 1.745 107 505 541
2023/202412.883 753 279 743 838 525 1.819 462 472 3.497 340 749 2.406
2024/202514.912 984 972 811 3.725 3.834 2.489 2.097 0 0 0 0 0
Totale 127.803